tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Positive Outlook on Ascendis Pharma Despite PDUFA Date Extension for TransCon CNP
PremiumRatingsPositive Outlook on Ascendis Pharma Despite PDUFA Date Extension for TransCon CNP
29d ago
Ascendis Pharma annouces FDA extension for TransCon CN
Premium
The Fly
Ascendis Pharma annouces FDA extension for TransCon CN
30d ago
FDA Calendar: These Are the Upcoming FDA Drug Approvals 
Premium
Market News
FDA Calendar: These Are the Upcoming FDA Drug Approvals 
1M ago
Ascendis Pharma: Promising Growth and Strong Market Penetration Justify Buy Rating
PremiumRatingsAscendis Pharma: Promising Growth and Strong Market Penetration Justify Buy Rating
1M ago
Strong Demand and Strategic Developments Drive Buy Rating for Ascendis Pharma
Premium
Ratings
Strong Demand and Strategic Developments Drive Buy Rating for Ascendis Pharma
1M ago
Ascendis Pharma Reports Strong Q3 2025 Performance
Premium
Company Announcements
Ascendis Pharma Reports Strong Q3 2025 Performance
1M ago
Ascendis Pharma reports Q3 EPS (EUR 1.00) vs. (EUR 0.72) last year
PremiumThe FlyAscendis Pharma reports Q3 EPS (EUR 1.00) vs. (EUR 0.72) last year
1M ago
ASND Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ASND Earnings this Week: How Will it Perform?
2M ago
Ascendis Pharma announces new pooled analysis on TransCon PTH
Premium
The Fly
Ascendis Pharma announces new pooled analysis on TransCon PTH
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100